Acute ischemic stroke outcomes in patients with COVID-19: a systematic review and meta-analysis

Sophia R Ferrone1, Maria X Sanmartin1,2, Joseph Ohara3

  • 1Institute for Health System Science, Northwell Health Feinstein Institutes for Medical Research, Manhasset, New York, USA.

Insights

Patients with acute ischemic stroke (AIS) and COVID-19 have significantly worse outcomes. This includes nearly fourfold increased mortality, reduced functional recovery, and less likelihood of returning home. COVID-19 substantially impacts early stroke prognosis.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 is associated with an increased risk of acute ischemic stroke (AIS).
  • The precise impact of COVID-19 on the clinical outcomes of AIS patients remains incompletely understood.
  • Understanding these outcomes is crucial for patient management and public health strategies.

Approach:

  • A systematic review and meta-analysis were conducted following PRISMA guidelines.
  • Searches were performed across major databases (EMBASE, PubMed, Web-of-Science, Scopus, CINAHL) up to June 3, 2021.
  • Random-effects models were used to pool data on mortality, functional outcomes (mRS), length of stay, and discharge disposition.

Key Points:

  • AIS patients with COVID-19 (AIS-COVID+) exhibited significantly higher in-hospital mortality compared to those without COVID-19 (AIS-COVID-).
  • AIS-COVID+ patients had poorer functional outcomes, indicated by lower rates of modified Rankin Scale (mRS) scores of 0-2.
  • These patients also experienced longer hospital stays and were less likely to be discharged to their homes.

Conclusions:

  • COVID-19 significantly worsens early outcomes for patients experiencing acute ischemic stroke.
  • The findings highlight a nearly fourfold increase in mortality and substantially reduced odds of favorable functional recovery and home discharge.
  • These results underscore the critical need for integrated care pathways for stroke patients with concurrent COVID-19 infections.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10